Coccidioidomycosis

Essentials of Clinical Mycology: Second Edition

Volumn , Issue , 2011, Pages 349-366

  Ampel, Neil M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864482095     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6640-7_20     Document Type: Chapter

References (214)

1. Rixford E, Gilchrist TC. Two cases of protozoon (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;1:209-68.
2. Ophüls W. Further observations on a pathogenic mould formerly described as a protozoan (Coccidioides immitis; Coccidioides pyogenes). J Exp Med. 1905;6:443-85.
3. Dickson EC, Gifford MA. Coccidioides infection (coccidioidomycosis) II. The primary type of infection. Arch Intern Med. 1938;62:853-71.
4. Smith CE. Epidemiology of acute coccidioidomycosis with erythema nodosum ("San Joaquin" or "Valley Fever"). Am J Public Health. 1940;30:600-11.
5. Smith CE, Whiting EG, Baker EE, Rosenberger HG, Beard R, Saito MT. The use of coccidioidin. Am Rev Tuberc. 1948;57:330-60.
6. Smith CE, Saito MT, Beard RR, Kepp RM, Clark RW, Eddie BU. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hyg. 1950;52:1-21.
7. Fiese MJ. Treatment of disseminated coccidioidomycosis with amphotericin B: report of a case. Calif Med. 1957;86:119-20.
8. Winn WA. The use of amphotericin B in the treatment of coccidioidal disease. Am J Med. 1959;27:617-35.
9. Fiese MJ. Treatment of disseminated coccidioidomycosis with amphotericin 8: report of a case calif Med 1951;86:119-20.
10. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part I. Am Rev Respir Dis. 1978;117:559-85.
11. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis. 1978;117:727-71.
12. Hirschmann JV. The early history of coccidioidomycosis: 1892- 1945. Clin Infect Dis. 2007;44:1202-7.
13. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol. 1988;2:199-238.
14. 2 in the morphogenesis of Coccidioides immitis in cellfree subcutaneous chambers. J Infect Dis. 1984;150:127-34.
15. Galgiani JN, Isenberg RA, Stevens DA. Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. Infect Immun. 1978;21:862-5.
16. Converse JL. Effect of surface active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J Bacteriol. 1957;74:106-7.
17. Sun SH, Huppert M. A cytological study of morphogenesis in Coccidioides immitis. Sabouraudia. 1976;14:185-98.
18. Stewart RA, Meyer KF. Isolation of Coccidioides immitis (Stiles) from the soil. Proc Soc Exp Biol Med. 1932;29:937-8.
19. Winn WA, Levine BE, Broderick JE, Crane RW. A localized epidemic of coccidioidal infection. N Engl J Med. 1963;268:867-70.
20. Wanke B, Lazera M, Monteiro PC, et al. Investigation of an outbreak of endemic coccidioidomycosis in Brazil's northeastern state of Piaui with a review of the occurrence and distribution of Coccidioides immitis in three other Brazilian states. Mycopathologia. 1999;148:57-67.
21. Egeberg RO, Ely AF. Coccidioides immitis in the soil of the southern San Joaquin Valley. Am J Med Sci. 1956;231:151-4.
22. Greene DR, Koenig G, Fisher MC, Taylor JW. Soil isolation and molecular identification of Coccidioides immitis. Mycologia. 2000;92:406-10.
23. Maddy KT. The geographic distribution of Coccidioides immitis and possible ecologic implications. Ariz Med. 1958;15:178-88.
24. Egeberg RO, Elconin AE, Egeberg MC. Effect of salinity and temperature on Coccidioides immitis and three antagonistic soil saphrophytes. J Bact. 1964;88:473-6.
25. Lacy GH, Swatek FE. Soil ecology of Coccidioides immitis at Amerindian middens in California. Appl Microbiol. 1974;27:379-88.
26. Petersen LR, Marshall SL, Barton-Dickson C, et al. Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis. 2004;10:637-42.
27. Fisher FS, Bultman MW, Johnson SM, Pappagianis D, Zaborsky E. Coccidioides niches and habitat parameters in the southwestern United States: A matter of scale. Ann NY Acad Sci. 2007;1111:47-72.
28. Bowman BH, Taylor JW, White TJ. Molecular evolution of the fungi: human pathogens. Mol Biol Evol. 1992;9:893-904.
29. Pan S, Sigler L, Cole GT. Evidence for a phylogenetic connection between Coccidioides immitis and Uncinocarpus reesii (Onygenaceae). Microbiology. 1994;140(Pt 6):1481-94.
30. Burt A, Carter DA, Koenig GL, White TJ, Taylor JW. Molecular markers reveal cryptic sex in the human pathogen Coccidioides immitis. Proc Natl Acad Sci USA. 1996;93:770-3.
31. Mandel MA, Barker BM, Kroken S, Rounsley SD, Orbach MJ. Genomic and population analyses of the mating type Loci in Coccidioides species reveal evidence for sexual reproduction and gene acquisition. Eukaryot Cell. 2007;6:1189-99.
32. Burt A, Dechairo BM, Koenig GL, Carter DA, White TJ, Taylor JW. Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas. Mol Ecol. 1997;6:781-6.
33. Fisher MC, Koenig GL, White TJ, et al. Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration. Proc Natl Acad Sci USA. 2001;98:4558-62.
34. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73-84.
35. de Aguiar Cordeiro R, Brilhante RS, Rocha MF, et al. Twelve years of coccidioidomycosis in Ceara State, Northeast Brazil: epidemiologic and diagnostic aspects. Diagn Microbiol Infect Dis. 2009;65(1):73-5.
36. Smith CE, Beard RR, Rosenberger HG, Whiting EG. Effect of season and dust control on coccidioidomycosis. JAMA. 1946;132:833-8.
37. Kerrick SS, Lundergan LL, Galgiani JN. Coccidioidomycosis at a university health service. Am Rev Respir Dis. 1985;131:100-2.
38. Comrie AC. Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ Health Perspect. 2005;113:688-92.
39. Park BJ, Sigel K, Vaz V, et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis. 2005;191:1981-7.
40. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med. 1978;129:527-30.
41. Flynn NM, Hoeprich PD, Kawachi MM, et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med. 1979;301:358-61.
42. Schneider E, Hajjeh RA, Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA. 1997;277:904-8.
43. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis. 1994;19 Suppl 1:S14-8.
44. CDC. Increase in Coccidioidomycosis - California, 2000-2007. MMWR Morb Mortal Wkly Rep. 2009;58:105-9.
45. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med. 1972;286:507-12.
46. Werner SB, Pappagianis D. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif Med. 1973;119:10-20.
47. Larsen RA, Jacobson JA, Morris AH, Benowitz BA. Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature. Am Rev Respir Dis. 1985;131:797-9.
48. Standaert SM, Schaffner W, Galgiani JN, et al. Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: An outbreak in a military reserve unit. J Infect Dis. 1995;171:1672-5.
49. Cairns L, Blythe D, Kao A, et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis. 2000;30:61-4.
50. CDC. Coccidioidomycosis in travelers returning from Mexico - Pennsylvania, 2000. MMWR Morb Mortal Wkly Rep. 2000;49:1004-6.
51. CDC. Coccidioidomycosis in workers at an archeologic site - Dinosaur National Monument, Utah, June-July 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1005-8.
52. Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and histoplasmin. Dis Chest. 1957;31:35-60.
53. Larwood TR. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis. 2000;30:612-3.
54. Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health. 1985;75:863-5.
55. Padua y Gabriel A, Martinez-Ordaz VA, Velasco-Rodreguez VM, Lazo-Saenz JG, Cicero R. Prevalence of skin reactivity to coccidioidin and associated risks factors in subjects living in a northern city of Mexico. Arch Med Res. 1999;30:388-92.
56. Johnson WM. Occupational factors in coccidioidomycosis. J Occup Med. 1981;23:367-74.
57. Looney JM, Coccidioidomycosis ST. The hazard involved in diagnostic procedures, with report of a case. N Engl J Med. 1950;242:77-82.
58. Johnson III JE, Perry JE, Fekety FR, Kadull PJ, Cluff LE. Laboratory-acquired coccidioidomycosis. Ann Intern Med. 1964;60:941-56.
59. Stevens DA, Clemons KV, Levine HB, et al. Expert opinion: What to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis. 2009;49:919-23.
60. Dixon DM. Coccidioides immitis as a select agent of bioterrorism. J Appl Microbiol. 2001;91:602-5.
61. Eckmann BH, Schaefer GL, Huppert M. Bedside interhuman transmission of coccidioidomycosis via growth on fomites. Am Rev Respir Dis. 1964;89:179-85.
62. Gehlbach SH, Hamilton JD, Conant NF. Coccidioidomycosis. An occupational disease in cotton mill workers. Arch Intern Med. 1973;131:254-5.
63. Ogiso A, Ito M, Koyama M, Yamaoka H, Hotchi M, McGinnis MR. Pulmonary coccidioidomycosis in Japan: case report and review. Clin Infect Dis. 1997;25:1260-1.
64. Stagliano D, Epstein J, Hickey P. Fomite-transmitted coccidioidomycosis in an immunocompromised child. Pediatr Infect Dis J. 2007;26:454-6.
65. Huntington RW. Pathology of coccidioidomycosis. In: Stevens DA, editor. Coccidioidomycosis a text. New York: Plenum Medical Book Company; 1980. p. 113-32.
66. Galgiani JN, Payne CM, Jones JF. Human polymorphonuclearleukocyte inhibition of incorporation of chitin precursors into mycelia of Coccidioides immitis. J Infect Dis. 1984;149:404-12.
67. Ragland AS, Arsura E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med. 1993;95:254-7.
68. Lombard CM, Tazelaar HD, Krasne DL. Pulmonary eosinophilia in coccidioidal infections. Chest. 1987;91:734-6.
69. Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis. 1982;4:656-64.
70. Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis. 1994;18:627-9.
71. Putnam JS, Harper WK, Greene Jr. JF, Nelson KG, Zurek RC. Coccidioides immitis. A rare cause of pulmonary mycetoma. Am Rev Respir Dis. 1975;112:733-8.
72. Rohatgi PK, Schmitt RG. Pulmonary coccidioidal mycetoma. Am J Med Sci. 1984;287:27-30.
73. Dolan MJ, Lattuada CP, Melcher GP, Zellmer R, Allendoerfer R, Rinaldi MG. Coccidioides immitis presenting as a mycelial pathogen with empyema and hydropneumothorax. J Med Vet Mycol. 1992;30:249-55.
74. Kleinschmidt-DeMasters BK, Mazowiecki M, Bonds LA, Cohn DL, Wilson ML. Coccidioidomycosis meningitis with massive dural and cerebral venous thrombosis and tissue arthroconidia. Arch Pathol Lab Med. 2000;124:310-4.
75. Chen KT. Coccidioidal peritonitis. Am J Clin Pathol. 1983;80:514-6.
76. Ampel NM, White JD, Varanasi UR, Larwood TR, Van Wyck DB, Galgiani JN. Coccidioidal peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1988;11:512-4.
77. Salgia K, Bhatia L, Rajashekaraiah KR, Zangan M, Hariharan S, Kallick CA. Coccidioidomycosis of the uterus. South Med J. 1982;75:614-6.
78. Bylund DJ, Nanfro JJ, Marsh Jr. WL. Coccidioidomycosis of the female genital tract. Arch Pathol Lab Med. 1986;110:232-5.
79. Sohail MR, Andrews PE, Blair JE. Coccidioidomycosis of the male genital tract. J Urol. 2005;173:1978-82.
80. Yurkanin JP, Ahmann F, Dalkin BL. Coccidioidomycosis of the prostate: A determination of incidence, report of 4 cases, and treatment recommendations. J Infect. 2006;52:e19-25.
81. Crum-Cianflone NF, Truett AA, Teneza-Mora N, et al. Unusual presentations of coccidioidomycosis: A case series and review of the literature. Medicine (Baltimore). 2006;85:263-77.
82. Weisman IM, Moreno AJ, Parker AL, Sippo WC, Liles WJ. Gastrointestinal dissemination of coccidioidomycosis. Am J Gastroenterol. 1986;81:589-93.
83. Kuntze JR, Herman MH, Evans SG. Genitourinary coccidioidomycosis. J Urol. 1988;140:370-4.
84. Polesky A, Kirsch CM, Snyder LS, et al. Airway coccidioidomycosis - report of cases and review. Clin Infect Dis. 1999;28:1273-80.
85. Rodenbiker HT, Ganley JP, Galgiani JN, Axline SG. Prevalence of chorioretinal scars associated with coccidioidomycosis. Arch Ophthalmol. 1981;99:71-5.
86. Rodenbiker HT, Ganley JP. Ocular coccidioidomycosis. Surv Ophthalmol. 1980;24:263-90.
87. Banuelos AF, Williams PL, Johnson RH, et al. Central nervous system abscesses due to Coccidioides species. Clin Infect Dis. 1996;22:240-50.
88. Mischel PS, Vinters HV. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis. 1995;20:400-5.
89. Williams PL, Johnson R, Pappagianis D, et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis. 1992;14:673-82.
90. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94:235-40.
91. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536-44.
92. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis. An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore). 1986;65:312-21.
93. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis. 1996;174:440-3.
94. Ampel NM, Kramer LA, Kerekes KM, Johnson SM, Pappagianis D. Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med Mycol. 2001;39:315-20.
95. Ampel NM, Kramer LA. In vitro modulation of cytokine production by lymphocytes in human coccidioidomycosis. Cell Immunol. 2003;221:115-21.
96. Li L, Dial SM, Schmelz M, Rennels MA, Ampel NM. Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis. Infect Immun. 2005;73:3923-8.
97. Smith CE, Beard R. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health. 1946;36:1394-402.
98. Richards JO, Ampel NM, Galgiani JN, Lake DF. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation. J Infect Dis. 2001;184:1220-4.
99. Levine BE, Cobb JM, Smith CE. Immunity to coccidioidomycosis induced mice by purified spherule, arthrospore, and mycelial vaccines. Trans NY Acad Sci. 1960;22:436-49.
100. Williams PL, Sable DL, Sorgen SP, et al. Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. Am J Epidemiol. 1984;119:591-602.
101. Pappagianis D. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis. 1993;148:656-60.
102. Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun. 1998;66:2342-5.
103. Jiang C, Magee DM, Quitugua TN, Cox RA. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect Immun. 1999;67:630-5.
104. Abuodeh RO, Shubitz LF, Siegel E, et al. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect Immun. 1999;67:2935-40.
105. Li K, Yu JJ, Hung CY, Lehmann PF, Cole GT. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice. Infect Immun. 2001;69:2878-87.
106. Xue J, Chen X, Selby D, Hung CY, Yu JJ, Cole GT. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun. 2009;77:3196-208.
107. Smith CE. Diagnosis of pulmonary coccidioidal infections. Calif Med. 1951;75:385-91.
108. Muir Bowers J, Mourani JP, Ampel NM. Fatigue in coccidioidomycosis. Quantification and correlation with clinical, immunological, and nutritional factors. Med Mycol. 2006;44:585-90.
109. Werner SB. Coccidioidomycosis misdiagnosed as contact dermatitis. Calif Med. 1972;117:59-61.
110. DiCaudo DJ, Yiannias JA, Laman SD, Warschaw KE. The exanthem of acute pulmonary coccidioidomycosis: clinical and histopathologic features of 3 cases and review of the literature. Arch Dermatol. 2006;142:744-6.
111. Arsura EL, Kilgore WB, Ratnayake SN. Erythema nodosum in pregnant patients with coccidioidomycosis. Clin Infect Dis. 1998;27:1201-3.
112. McGahan JP, Graves DS, Palmer PE, Stadalnik RC, Dublin AB. Classic and contemporary imaging of coccidioidomycosis. AJR. 1981;136:393-404.
113. Greendyke WH, Resnick DL, Harvey WC. The varied roentgen manifestations of primary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med. 1970;109:491-9.
114. Merchant M, Romero AO, Libke RD, Joseph J. Pleural effusion in hospitalized patients with coccidioidomycosis. Respir Med. 2008;102:537-40.
115. Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006;12:958-62.
116. Capone D, Marchiori E, Wanke B, et al. Acute pulmonary coccidioidomycosis: CT findings from 15 patients. Br J Radiol. 2008;81:721-4.
117. Forseth J, Rohwedder JJ, Levine BE, Saubolle MA. Experience with needle biopsy for coccidioidal lung nodules. Arch Intern Med. 1986;146:319-20.
118. Chitkara YK. Evaluation of cultures of percutaneous core needle biopsy specimens in the diagnosis of pulmonary nodules. Am J Clin Pathol. 1997;107:224-8.
119. Winn RE, Johnson R, Galgiani JN, Butler C, Pluss J. Cavitary coccidioidomycosis with fungus ball formation. Diagnosis by fiberoptic bronchoscopy with coexistence of hyphae and spherules. Chest. 1994;105:412-6.
120. Hyde L. Coccidioidal pulmonary cavitation. Dis Chest. 1968;54 Suppl 1:273-7.
121. Edelstein G, Levitt RG. Cavitary coccidioidomycosis presenting as spontaneous pneumothorax. AJR. 1983;141:533-4.
122. Sarosi GA, Parker JD, Doto IL, Tosh FE. Chronic pulmonary coccidioidomycosis. N Engl J Med. 1970;283:325-9.
123. Arsura EL, Kilgore WB. Miliary coccidioidomycosis in the immunocompetent. Chest. 2000;117:404-9.
124. Rempe S, Sachdev MS, Bhakta R, Pineda-Roman M, Vaz A, Carlson RW. Coccidioides immitis fungemia: clinical features and survival in 33 adult patients. Heart Lung. 2007;36:64-71.
125. Adam RD, Elliott SP, Taljanovic MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009;122:770-7.
126. Caldwell JW, Arsura EL, Kilgore WB, Reddy CM, Johnson RH. Hypercalcemia in patients with disseminated coccidioidomycosis. Am J Med Sci. 2004;327:15-8.
127. Hobbs ER. Coccidioidomycosis. Dermatol Clin. 1989;7:227-39.
128. Kushwaha VP, Shaw BA, Gerardi JA, Oppenheim WL. Musculoskeletal coccidioidomycosis. A review of 25 cases. Clin Orthop Relat Res. 1996:190-9.
129. Zeppa MA, Laorr A, Greenspan A, McGahan JP, Steinbach LS. Skeletal coccidioidomycosis: Imaging findings in 19 patients. Skeletal Radiol. 1996;25:337-43.
130. Olson EM, Duberg AC, Herron LD, Kissel P, Smilovitz D. Coccidioidal spondylitis: MR findings in 15 patients. AJR. 1998;171:785-9.
131. Bayer AS, Guze LB. Fungal arthritis. II. Coccidioidal synovitis: clinical, diagnostic, therapeutic, and prognostic considerations. Semin Arthritis Rheum. 1979;8:200-11.
132. Lund PJ, Chan KM, Unger EC, Galgiani TN, Pitt MJ. Magnetic resonance imaging in coccidioidal arthritis. Skeletal Radiol. 1996;25:661-5.
133. Bouza E, Dreyer JS, Hewitt WL, Meyer RD. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore). 1981;60:139-72.
134. Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42:103-7.
135. Vincent T, Galgiani JN, Huppert M, Salkin D. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. Clin Infect Dis. 1993;16:247-54.
136. Erly WK, Bellon RJ, Seeger JF, Carmody RF. MR imaging of acute coccidioidal meningitis. AJNR. 1999;20:509-14.
137. Williams PL. Vasculitic complications associated with coccidioidal meningitis. Semin Respir Infect. 2001;16:270-9.
138. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine (Baltimore). 1975;54:377-95.
139. Masannat FY, Ampel NM. Coccidioidomycosis among patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50:1-7.
140. Mortimer RB, Libke R, Eghbalieh B, Bilello JF. Immune reconstitution inflammatory syndrome presenting as superior vena cava syndrome secondary to Coccidioides lymphadenopathy in an HIVinfected patient. J Int Assoc Physicians AIDS Care (Chic Ill). 2008;7:283-5.
141. Blair JE. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis. 2008;21:415-20.
142. Blair JE, Kusne S, Carey EJ, Heilman RL. The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Transplantation. 2007;83:1182-7.
143. Wright P, Pappagianis D, Taylor J, et al. Transmission of Coccidioides immitis from donor organs: A description of two fatal cases of disseminated coccidioidomycosis [Abstract 619]. In: Annual Conference of the Infectious Diseases Society of America 2001, San Francisco, CA; 2001.
144. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg. 2002;73:306-8.
145. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol. 2004;42:2347-9.
146. Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis. 2007;9:78-82.
147. Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy. Drugs. 2009;69:1403-15.
148. Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004;50:1959-66.
149. Dweik M, Baethge BA, Duarte AG. Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab. South Med J. 2007;100:517-8.
150. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. IDSA Guidelines. Clin Infect Dis. 2005;41:1217-23.
151. Gray GC, Fogle EF, Albright KL. Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994. Am J Trop Med Hyg. 1998;58:309-12.
152. Arsura EL. The association of age and mortality in coccidioidomycosis. J Am Geriatr Soc. 1997;45:532-3.
153. Ampel NM, Mosley DG, England B, Vertz PD, Komatsu K, Hajjeh RA. Coccidioidomycosis in Arizona: Increase in incidence from 1990 to 1995. Clin Infect Dis. 1998;27:1528-30.
154. Leake JA, Mosley DG, England B, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis. 2000;181:1435-40.
155. Williams PL, Sable DL, Mendez P, Smyth LT. Symptomatic coccidioidomycosis following a severe natural dust storm. An outbreak at the Naval Air Station, Lemoore, California. Chest. 1979;76:566-70.
156. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis. 2001;32:708-15.
157. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119(993):e11-7.
158. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis. 1996;22:336-40.
159. De Santis M, Di Gianantonio E, Cesari E, Ambrosini G, Straface G, Clementi M. First-trimester itraconazole exposure and pregnancy outcome: A prospective cohort study of women contacting teratology information services in Italy. Drug Saf. 2009;32:239-44.
160. Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol. 1993;31:845-50.
161. Stevens DA, Clemons KV, Levine HB, et al. Expert opinion: What to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis. 2009;49:919-23.
162. DiTomasso JP, Ampel NM, Sobonya RE, Bloom JW. Bronchoscopic diagnosis of pulmonary coccidioidomycosis. Comparison of cytology, culture, and transbronchial biopsy. Diagn Microbiol Infect Dis. 1994;18:83-7.
163. Sarosi GA, Lawrence JP, Smith DK, Thomas A, Hobohm DW, Kelley PC. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect. 2001;16:238-41.
164. Smith CE, Saito MT, Simons SA. Pattern of 39, 500 serologic tests in coccidioidomycosis. JAMA. 1956;160:546-52.
165. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3:247-68.
166. Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect. 2001;16:242-50.
167. Hung CY, Yu JJ, Lehmann PF, Cole GT. Cloning and expression of the gene which encodes a tube precipitin antigen and wall-associated beta-glucosidase of Coccidioides immitis. Infect Immun. 2001;69:2211-22.
168. Zimmermann CR, Johnson SM, Martens GW, White AG, Pappagianis D. Cloning and expression of the complement fixation antigen-chitinase of Coccidioides immitis. Infect Immun. 1996;64:4967-75.
169. Huppert M, Bailey JW. The use of immunodiffusion tests in coccidioidomycosis. I. The accuracy and reproducibility of the immunodiffusion test which correlates with complement fixation. Am J Clin Pathol. 1965;44:364-8.
170. Huppert M, Bailey JW. The use of immunodiffusion tests in coccidioidomycosis. II. An immunodiffusion test as a substitute for the tube precipitin test. Am J Clin Pathol. 1965;44:369-73.
171. Wieden MA, Galgiani JN, Pappagianis D. Comparison of immunodiffusion techniques with standard complement fixation assay for quantitation of coccidioidal antibodies. J Clin Microbiol. 1983;18:529-34.
172. Kaufman L, Sekhon AS, Moledina N, Jalbert M, Pappagianis D. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol. 1995;33:618-9.
173. Blair JE, Currier JT. Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia. 2008;166:77-82.
174. Antoniskis D, Larsen RA, Akil B, Rarick MU, Leedom JM. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS. 1990;4:691-3.
175. Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006;162:317-24.
176. Kuberski T, Myers R, Wheat LJ, et al. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis. 2007;44:e50-4.
177. Durkin M, Connolly P, Kuberski T, et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis. 2008;47:e69-73.
178. Bialek R, Kern J, Herrmann T, et al. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J Clin Microbiol. 2004;42:778-83.
179. Johnson SM, Simmons KA, Pappagianis D. Amplification of coccidioidal DNA in clinical specimens by PCR. J Clin Microbiol. 2004;42:1982-5.
180. Brilhante RS, Cordeiro RA, Rocha MF, et al. Coccidioidal pericarditis: A rapid presumptive diagnosis by an in-house antigen confirmed by mycological and molecular methods. J Med Microbiol. 2008;57:1288-92.
181. Cordeiro RA, Brilhante RSN, Rocha MFG, Moura FEA, Camargo ZP, Sidrim JJC. Rapid diagnosis of coccidioidomycosis by nested PCR assay of sputum. Clin Microbiol Infect. 2007;13:449-51.
182. Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45:173-8.
183. Hardenbrook MH, Barriere SL. Coccidioidomycosis: evaluation of parameters used to predict outcome with amphotericin B therapy. Mycopathologia. 1982;78:65-71.
184. Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA. Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. Am J Med. 1990;89:282-90.
185. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med. 1995;98:249-56.
186. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. The NIAIDMycoses Study Group. Ann Intern Med. 2000;133:676-86.
187. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med. 1993;119:28-35.
188. Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med. 1990;112:108-12.
189. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. 2005;40:1770-6.
190. Stevens DA, Rendon A, Gaona-Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007;132:952-8.
191. Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007;45:562-8.
192. Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis. 2003;36:1619-22.
193. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004;39:e74-7.
194. Proia LA, Tenorio AR. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother. 2004;48:2341.
195. Gonzalez GM, Tijerina R, Najvar LK, et al. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother. 2001;45:1854-9.
196. Park DW, Sohn JW, Cheong HJ, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis. 2006;6:26.
197. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother. 2004;54:292-4.
198. Hector RF, Zimmer BL, Pappagianis D. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother. 1990;34:587-93.
199. Kuberski TT, Servi RJ, Rubin PJ. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis. 2004;38:910-2.
200. Ramani R, Chaturvedi V. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas. Mycopathologia. 2007;163:315-9.
201. Kriesel JD, Sutton DA, Schulman S, Fothergill AW, Rinaldi MG. Persistent pulmonary infection with an azole-resistant Coccidioides species. Med Mycol. 2008;46:607-10.
202. Baddley JW, Cobbs CS, Pappas PG. Surgical treatment of multiple skull abscesses associated with coccidioidomycosis. Mycoses. 2004;47:69-71.
203. Romeo JH, Rice LB, McQuarrie IG. Hydrocephalus in coccidioidal meningitis: case report and review of the literature. Neurosurgery. 2000;47:773-7.
204. Wrobel CJ, Chappell ET, Taylor W. Clinical presentation, radiological findings, and treatment results of coccidioidomycosis involving the spine: report on 23 cases. J Neurosurg. 2001;95:33-9.
205. Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009;48:172-8.
206. Sugar AM. Use of amphotericin B with azole antifungal drugs. What are we doing? Antimicrob Agents Chemother. 1995;39:1907-12.
207. Rex JH, Pappas PG, Karchmer AW, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis. 2003;36:1221-8.
208. Oldfield 3rd EC, Bone WD, Martin CR, Gray GC, Olson P, Schillaci RF. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis. 1997;25:1205-10.
209. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000;133:676-86.
210. Einstein H, Holeman CW, Sandidge LL, Holden DH. Coccidioidal meningitis. The use of amphotericin B in treatment. Calif Med. 1961;94:339-43.
211. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124:305-10.
212. Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect. 2001;16:263-9.
213. Berry CD, Stevens DA, Hassid EI, Pappagianis D, Happs EL, Sahrakar K. A new method for the treatment of chronic fungal meningitis: continuous infusion into the cerebrospinal fluid for coccidioidal meningitis. Am J Med Sci. 2009;338:79-82.
214. Kirkland TN, Fierer J. Coccidioidomycosis: A reemerging infectious disease. Emerg Infect Dis. 1996;2:192-9.